| Gujarat Themis Biosyn Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506879 |
NSE Symbol : GUJTHEM |
P/E(TTM) : 83.29 |
|
ISIN Demat : INE942C01045 |
Div & Yield% : 0.19 |
EPS(TTM) : 4.28 |
|
Book Value(₹) : 26.41 |
Market Cap(₹Cr) : 3,884.61 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 43.79 | 44.23 | 43.37 | 42.35 | 35.87 | 37.74 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 43.79 | 44.23 | 43.37 | 42.35 | 35.87 | 37.74 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.13 | 0.92 | 0.42 | 0.82 | 0.27 | 1.35 |
| Total Income | 43.92 | 45.15 | 43.78 | 43.17 | 36.15 | 39.08 |
| Total Expenditure | 23.00 | 24.87 | 22.06 | 21.41 | 21.95 | 21.70 |
| PBIDT | 20.93 | 20.28 | 21.72 | 21.76 | 14.20 | 17.39 |
| Interest | 1.79 | 1.91 | 0.96 | 0.04 | 0.04 | 0.07 |
| PBDT | 19.14 | 18.37 | 20.76 | 21.72 | 14.15 | 17.32 |
| Depreciation | 3.97 | 4.04 | 3.89 | 2.96 | 2.03 | 1.23 |
| Tax | 2.72 | 2.38 | 2.86 | 3.08 | 2.47 | 3.86 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.38 | 1.07 | 1.55 | 1.41 | 0.59 | 0.23 |
| Reported Profit After Tax | 11.07 | 10.89 | 12.46 | 14.26 | 9.06 | 12.00 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 11.07 | 10.89 | 12.46 | 14.26 | 9.06 | 12.00 |
| EPS (Unit Curr.) | 1.02 | 1.00 | 1.14 | 1.31 | 0.83 | 1.10 |
| EPS (Adj) (Unit Curr.) | 1.02 | 1.00 | 1.14 | 1.31 | 0.83 | 1.10 |
| Calculated EPS (Unit Curr.) | 1.02 | 1.00 | 1.14 | 1.31 | 0.83 | 1.10 |
| Calculated EPS (Adj) (Unit Curr.) | 1.02 | 1.00 | 1.14 | 1.31 | 0.83 | 1.10 |
| Calculated EPS (Ann.) (Unit Curr.) | 4.06 | 4.00 | 4.58 | 5.24 | 3.33 | 4.40 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.06 | 4.00 | 4.58 | 5.24 | 3.33 | 4.40 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.90 | 10.90 | 10.90 | 10.90 | 10.90 | 10.90 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 47.80 | 45.85 | 50.08 | 51.38 | 39.59 | 46.08 |
| PBDTM(%) | 43.71 | 41.53 | 47.87 | 51.29 | 39.45 | 45.89 |
| PATM(%) | 25.28 | 24.62 | 28.73 | 33.67 | 25.26 | 31.80 |
